REQUEST A DEMO
Total
USD $0.00
Search more companies

Sumitomo Pharma Asia Pacific Pte. Ltd. (Singapore)

Main Activities: Corporate, Subsidiary, and Regional Managing Offices
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sumitomo Pharma Asia Pacific Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Primary Business Activity: activities of head and regional head offices; centralised administrative offices and subsidiary management offices (liaison office & regional headquarter, south east asia & its surrounding area); Secondary Business Activity: wholesale of medicinal and pharmaceutical products (western)

Headquarters
3 Fraser Street, #07-28 Duo Tower, Singapore
Singapore; Singapore; Postal Code: 189352

Contact Details: Purchase the Sumitomo Pharma Asia Pacific Pte. Ltd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sumitomo Pharma Asia Pacific Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Sumitomo Pharma Asia Pacific Pte. Ltd. report to view the information.
Incorporation Date:
January 17, 2013
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sumitomo Pharma Asia Pacific Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
64.44%
Total operating revenue
64.44%
Net Profit (Loss) for the Period
140.92%
Total assets
35.47%
Total equity
22.88%
Net Profit Margin
2.71%
Return on Equity (ROE)
9.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?